PAR •
Healthcare •
Biotechnology •
Quote as of 06/12/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangePAR
Market Capitalization6.48 mln
Float17.38 mln
EPS
0.30
Marginal
P / E
1.19
Deeply undervalued
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-0.2
Highly suspicious
Relative Strength
6
/ 100
Severely lagging
Debt / Equity
0.12
Very low leverage
Business Description
Founded in 1995 and headquartered in Dijon, France, Oncodesign Precision Medicine is a biopharmaceutical company developing targeted therapies for serious diseases including cancer, inflammatory bowel disease, and Parkinson's disease. Its lead drug candidates work by blocking specific proteins linked to disease progression, while a separate line of research focuses on molecules that can both detect and treat advanced digestive and pancreatic cancers in a single approach.
